Difference between revisions of "Medroxyprogesterone acetate (MPA)"
Jump to navigation
Jump to search
m |
m |
||
| Line 7: | Line 7: | ||
==History of changes in EMA indication== | ==History of changes in EMA indication== | ||
| − | * | + | *1959-08-20: EURD |
| + | |||
==Also known as== | ==Also known as== | ||
*'''Generic names:''' medroxyprogesterone acetate, MPA | *'''Generic names:''' medroxyprogesterone acetate, MPA | ||
| Line 25: | Line 26: | ||
[[Category:FDA approved in 1959]] | [[Category:FDA approved in 1959]] | ||
| − | [[Category:EMA approved in | + | [[Category:EMA approved in 1959]] |
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 23:13, 13 June 2023
Diseases for which it is used
Diseases for which it was used
History of changes in EMA indication
- 1959-08-20: EURD
Also known as
- Generic names: medroxyprogesterone acetate, MPA
- Brand names: Depo-Provera, Provera